S100A3 Antibody (05) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06623UV
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 05
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human S100A3 (Uniprot#: P33764; Met 1-Gln 101).
Reactivity Notes
No cross-reactivity in ELISA with:
E.coli cell lysate
E.coli cell lysate
Specificity
No cross-reactivity in ELISA with: E.coli cell lysate
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for S100A3 Antibody (05) [DyLight 350]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: S100A3
Alternate Names
Protein S-100E, S100 calcium binding protein A3, S100 calcium-binding protein A3S100Eprotein S100-A3
Gene Symbol
S100A3
Additional S100A3 Products
Product Documents for S100A3 Antibody (05) [DyLight 350]
Product Specific Notices for S100A3 Antibody (05) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...